Emory University: Lung Neoplasms trials

The registry lists 17 Lung Neoplasms studies with Emory University as lead sponsor. 5 are open to participants now and 5 have results posted.

Early Phase 1 1Phase 1 9Phase 2 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent ImmunotherapyRecruitingNCT06731270Phase 2
• Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung CancerRecruitingNCT06495125Phase 2
• Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerRecruitingNCT05493566Early Phase 1
• Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung CancerRecruitingNCT05244239Phase 1
• MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung CancerRecruitingNCT04762199Phase 1
• Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell CarcinomaTerminatedNCT04495894Phase 2Results posted
• Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung CancerTerminatedNCT04348292Phase 1Results posted
• Study of Arsenic Trioxide in Small Cell Lung CancerCompletedNCT01470248Phase 2Results posted
• Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung CancerTerminatedNCT00406276Phase 1/2Results posted
• Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00401778Phase 1Results posted
• Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 BlockadeActive, not recruitingNCT04340882Phase 2
• Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT04262869Phase 2
• Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCompletedNCT03493789Phase 1
• Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung CancerWithdrawnNCT03121417Phase 2
• Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompletedNCT02897375Phase 1
• An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01711697Phase 1
• A Phase I Study of BKM120 and Everolimus in Advanced Solid MalignanciesCompletedNCT01470209Phase 1